TITLE

A prospective longitudinal study of apathy in Alzheimer's disease

AUTHOR(S)
Starkstein, S. E.; Jorge, R.; Mizrahi, R.; Robinson, R. G.
PUB. DATE
January 2006
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan2006, Vol. 77 Issue 1, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Apathy and depression are the most frequent behavioural and psychiatric disorders in Alzheimer's disease, and may both have a negative impact on the progression of the illness. Objectives: To examine the clinical correlates of apathy in Alzheimer's disease (AD), and to determine whether apathy is a significant predictor of more rapid cognitive, functional and emotional decline. Methods: Using a structured psychiatric evaluation, we examined a consecutive series of 354 subjects meeting clinical criteria for AD. Apathy was assessed by the Apathy Scale, and diagnosed using standardised criteria. Additional measurements included scales for depression, functional impairment, and global cognitive functions. A follow up evaluation was carried out in 247 patients (70% of the total sample) between 1 and 4 years after the baseline evaluation. Results: Apathy was significantly associated with older age (p = 0.009), and a higher frequency of minor and major depression (p<0.0001). Apathy at baseline was a significant predictor of depression at follow up (p =0.01), and was associated with a faster cognitive (p = 0.0007) and functional decline (p = 0.006). Conclusions: Apathy in AD is a behavioural marker of a more aggressive dementia, characterised by a faster progression of cognitive, functional, and emotional impairment.
ACCESSION #
19519138

 

Related Articles

  • Clinical Tests of Memory. Kopelman, Michael D. // British Journal of Psychiatry;May86, Vol. 148, p517 

    This study compared the performance of groups Alzheimer, Korsakoff, and depressed patients and a group of healthy controls at various clinical tests of memory, and wide differences were found in the discriminatory power of the different tests. In addition, the patterns of performance of the...

  • Bilaterally reduced claustral volumes in schizophrenia and major depressive disorder: a morphometric postmortem study. Bernstein, Hans-Gert; Ortmann, Anna; Dobrowolny, Henrik; Steiner, Johann; Brisch, Ralf; Gos, Tomasz; Bogerts, Bernhard // European Archives of Psychiatry & Clinical Neuroscience;Feb2016, Vol. 266 Issue 1, p25 

    Multiple brain structural abnormalities have been reported in schizophrenia and major depressive disorder. A majority of disease-affected brain regions act as relay nodes within neural networks, which are known to be impaired in neuropsychiatric diseases. One of these regions is the claustrum,...

  • Review: Antidepressants improve depression in people with Alzheimer's disease. Lyketsos, Constantine G.; Plank Althouse, Elizabeth // Evidence Based Mental Health;Nov2007, Vol. 10 Issue 4, p115 

    The article attempts to determine whether antidepressants are effective and safe for people with depression and Alzheimer's disease. It shows that antidepressants increase response and remission of depressive symptoms compared with placebo in people with Alzheimer's disease and depression when...

  • DOME DEFENSE.  // Men's Health;Dec2007, Vol. 22 Issue 10, p85 

    The article offers pieces of advice on how to avoid various types of mental disorders. According to a study in Human Psychopharmacology, low levels of the mineral have been linked to depression. Thus, the study suggests increasing magnesium intake to fight depression. Meanwhile, people with high...

  • Methodological Issues in Designing a Randomized Controlled Trial for Psychotic Depression: The STOP-PD Study. Meyers, Barnett S.; Peasley-Miklus, Catherine; Flint, Alastair J.; Mulsant, Benoit H.; Rothschild, Anthony J. // Psychiatric Annals;Jan2006, Vol. 36 Issue 1, p57 

    Discusses methodological issues in designing a randomized controlled trial for psychotic depression. Purpose of the Study of the Treatment of Psychotic Depression; Identification of methodological challenges of randomized trial of patients with major depressive disorder with psychotic features;...

  • How to manage depression and psychosis in Alzheimer's disease. Tueth, Michael J. // Geriatrics;Jan95, Vol. 50 Issue 1, p43 

    Focuses on the management of depression and psychosis in patients with Alzheimer's disease. Determination of risk factors; Identification and diagnosis of symptoms; Nondrug and drug-based therapies.

  • RESEARCHING A BETTER FUTURE. Wilkniss, Sandra // Behavioral Healthcare;Jun2006, Vol. 26 Issue 6, p49 

    Focuses on behavioral health studies and their impact on parity in the Federal Employees Health Benefits Program in the U.S. Study which found that parity implementation did not lead to higher costs; Information on the Clinical Antipsychotic Trials of Intervention Effectiveness; Findings of the...

  • The Distinction Between the Affective Psychoses and Schizophrenia. Brockington, I. F.; Kendell, R. E.; Wainwright, S.; Hillier, V. F.; Walker, J. // British Journal of Psychiatry;Sep79, Vol. 135, p243 

    In an attempt to demonstrate a valid boundary between schizophrenia and the affective psychoses, discriminant function analyses have been carried out with history, mental state and follow-up data in two populations of patients. A bimodal distribution of discriminant scores was obtained in one of...

  • Exposure to obstetric complications and subsequent development of bipolar disorder: Systematic review.  // British Journal of Psychiatry;Jul2006, Vol. 189, p3 

    Background Research has suggested an association between obstetric complications and bipolar disorder. However, no quantitative evaluation has been made of the pooled data from existing studies. Aims To systematically review studies comparing exposure to obstetric complications in cases of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics